Concepedia

Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double‐blind placebo‐controlled trial

Antonellá Tosti, Matilde Iorizzo, Gian Luca Botta, Massimo Milani

Journal of the European Academy of Dermatology and Venereology · 2006 · 127 citations · 11 references

DOI

Abstract

This new formulation of clobetasol propionate foam is an effective, safe and well-tolerated topical treatment for AA. This formulation has a good cosmetic acceptance and patient compliance profile.

References

11

Alopecia areata investigational assessment guidelines–Part II

Elise A. Olsen, Maria K. Hordinsky, Vera H. Price et al. · Journal of the American Academy of Dermatology · 2004 · 764 citations

, , +3

Guidelines for the management of alopecia areata

S.P. MacDonald Hull, Michelle Wood, P.E. Hutchinson et al. · British Journal of Dermatology · 2003 · 224 citations

, , +6

Diabetes Prolongs the Inflammatory Response to a Bacterial Stimulus Through Cytokine Dysregulation

Ghada H. Naguib, Hesham Almashat, Tesfahun Desta et al. · Journal of Investigative Dermatology · 2004 · 221 citations

, , +8

Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis

Antonellá Tosti, Bianca Maria Piraccini, Massimiliano Pazzaglia et al. · Journal of the American Academy of Dermatology · 2003 · 175 citations

, , +2

Placebo-controlled oral pulse prednisolone therapy in alopecia areata

Bikash Ranjan Kar, Sanjeev Handa, Sunil Dogra et al. · Journal of the American Academy of Dermatology · 2005 · 143 citations

, , +6